The following study addresses the hypothesis that an additional factor affecting venetoclax resistance is the selective loss of its target, BCL2, within the actively dividing subset of CLL cells in pseudofollicles [30]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.